Therapeuticsmd Inc (TXMD) Stock Price, Quote & News

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 561 961 1900

Website: www.therapeuticsmd.com

Address:

951 Yamato Road, Suite 220, Boca Raton, United States

lexlut Oct. 3 at 7:34 PM

$CMPX $OCGN $TXMD

0 · Reply

lexlut Oct. 3 at 1:51 PM

$OCGN $CMPX $TXMD

1 · Reply

jfer333 Oct. 3 at 3:33 AM

⚖️ $TXMD Court Update – 10/2 Judge Andrews has referred 2 major motions to Magistrate Judge Eleanor Tennyson: 1️⃣ Mayne’s Motion to Dismiss 2️⃣ Mayne’s Motion to Compel Arbitration/Stay 👉 This means no ruling yet — instead, the magistrate will review and issue recommendations before Andrews makes a final decision. ✅ Significance: adds a step & some delay, but the core fight stays alive: TXMD wants trial in court, Mayne wants arbitration. Both sides now reargue before the magistrate.

0 · Reply

lexlut Oct. 2 at 7:59 PM

$OCGN Buy $TXMD

0 · Reply

YPOJOB Oct. 1 at 11:12 PM

$TXMD Ask Grok best case scenario. Use court cases. WOW.

1 · Reply

JJYLT Oct. 1 at 8:58 AM

$TXMD

0 · Reply

ekraus Sep. 30 at 2:19 PM

$TXMD this could go under a buck again

0 · Reply

mwhite9869 Sep. 29 at 10:48 PM

$TXMD just checking in.....worth getting into this yet or still a mess with Court crap? Yeah, I could look into it myself. This is easier.

0 · Reply

ekraus Sep. 29 at 7:17 AM

$TXMD seems few or no longs post here

0 · Reply

ekraus Sep. 29 at 7:13 AM

$TXMD why did stockholders refuse $10 per share

0 · Reply

TherapeuticsMD Announces Second Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 5 months ago

TherapeuticsMD Announces First Quarter 2025 Financial Results

Mar 27, 2025, 4:05 PM EDT - 6 months ago

TherapeuticsMD Announces Full Year 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 11 months ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Aug 26, 2024, 7:36 AM EDT - 1 year ago

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces Second Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces First Quarter 2024 Financial Results

Mar 29, 2024, 4:00 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 2 years ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results

May 23, 2023, 9:00 AM EDT - 2 years ago

TherapeuticsMD: From Fallen And Forgotten To Cash Cow

May 15, 2023, 4:05 PM EDT - 2 years ago

TherapeuticsMD Announces First Quarter 2023 Financial Results

Apr 7, 2023, 4:01 PM EDT - 2 years ago

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Jan 3, 2023, 6:50 AM EST - 2 years ago

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

Dec 4, 2022, 6:00 PM EST - 3 years ago

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

Nov 14, 2022, 4:05 PM EST - 3 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results

Oct 31, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Additional $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces $7 Million Private Placement

Sep 12, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

Aug 15, 2022, 9:46 AM EDT - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call Transcript

Aug 15, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 8, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

Aug 1, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Jul 13, 2022, 9:59 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 8:25 AM EDT - 3 years ago

TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Expiration of Tender Offer

Jul 6, 2022, 6:09 AM EDT - 3 years ago

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

Jun 21, 2022, 12:01 PM EDT - 3 years ago

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

WEBR

Jun 16, 2022, 2:43 PM EDT - 3 years ago

TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback

Jun 13, 2022, 10:49 AM EDT - 3 years ago

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

BEEM

Jun 6, 2022, 4:05 PM EDT - 3 years ago

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

May 31, 2022, 7:34 PM EDT - 3 years ago

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

May 31, 2022, 1:57 PM EDT - 3 years ago

Here is why TherapeuticsMD jumped 300%

May 31, 2022, 10:12 AM EDT - 3 years ago

Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 6:00 AM EDT - 3 years ago

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

May 20, 2022, 10:54 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 9:43 AM EDT - 3 years ago

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

May 16, 2022, 8:07 PM EDT - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript

May 16, 2022, 4:05 PM EDT - 3 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results

May 10, 2022, 4:05 PM EDT - 3 years ago

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

Apr 14, 2022, 4:15 PM EDT - 3 years ago

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

GDRX

Mar 14, 2022, 8:39 AM EDT - 3 years ago

TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business

Mar 10, 2022, 10:35 AM EST - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd On Q4 2021 Results - Earnings Call Transcript

Mar 10, 2022, 6:50 AM EST - 3 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 7, 2022, 9:38 AM EST - 3 years ago

Why TherapeuticsMD Shares Are Soaring Today

Mar 7, 2022, 7:57 AM EST - 3 years ago

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

lexlut Oct. 3 at 7:34 PM

$CMPX $OCGN $TXMD

0 · Reply

lexlut Oct. 3 at 1:51 PM

$OCGN $CMPX $TXMD

1 · Reply

jfer333 Oct. 3 at 3:33 AM

0 · Reply

lexlut Oct. 2 at 7:59 PM

$OCGN Buy $TXMD

0 · Reply

YPOJOB Oct. 1 at 11:12 PM

$TXMD Ask Grok best case scenario. Use court cases. WOW.

1 · Reply

JJYLT Oct. 1 at 8:58 AM

$TXMD

0 · Reply

ekraus Sep. 30 at 2:19 PM

$TXMD this could go under a buck again

0 · Reply

mwhite9869 Sep. 29 at 10:48 PM

$TXMD just checking in.....worth getting into this yet or still a mess with Court crap? Yeah, I could look into it myself. This is easier.

0 · Reply

ekraus Sep. 29 at 7:17 AM

$TXMD seems few or no longs post here

0 · Reply

ekraus Sep. 29 at 7:13 AM

$TXMD why did stockholders refuse $10 per share

0 · Reply

ekraus Sep. 27 at 3:54 AM

$TXMD could this drop back below a buck again?

0 · Reply

ekraus Sep. 27 at 3:54 AM

$TXMD boy, this boaed has really hit the skids . good luck, but do not hold your breath

0 · Reply

navigatord7 Sep. 26 at 11:22 PM

$TXMD something is fermenting.

0 · Reply

Bio_Invest101 Sep. 24 at 10:15 PM

$TXMD Updates https://www.afr.com/companies/healthcare-and-fitness/mayne-pharma-director-questioned-management-integrity-court-hears-20250921-p5mwsx

1 · Reply

JJYLT Sep. 22 at 8:08 AM

$TXMD interesting

0 · Reply

YPOJOB Sep. 17 at 11:06 PM

$TXMD

0 · Reply

h8ster Sep. 12 at 9:20 PM

$TXMD Mayne now motioning for the judge to allow them oral arguments to dismiss TXMD's case, as the judge seems to be taking his time with his decision. They are worried. LMAOF. Hope Mayne gets destroyed.

2 · Reply

YPOJOB Sep. 11 at 9:30 PM

$TXMD The validity of Cosette's termination attempts is set for a Supreme Court hearing starting September 22, 2025, leaving the outcome uncertain. The other cases I think need to be completed before this happens. I am not a guru on this. But it would make sense

0 · Reply

h8ster Sep. 9 at 7:40 PM

$TXMD On the 8th, TXMD filed their final arguments against Mayne's arguments not to dismiss their claims. Now it is in the hands of the judge to decide if Mayne's countersuit against TXMD is to be dismissed. On the 5th, Mayne filed their final argument against TXMD's arguments not to dismiss their claims. Now that is in the hands of the judge to decide if TXMD's suit against Mayne is to be dismissed. Both cases are in the hands of Judge Richard G. Andrews. He's gotta be like, "WTF"

2 · Reply

JJYLT Sep. 8 at 10:25 AM

$TXMD ⌚️

0 · Reply

jfer333 Sep. 6 at 1:09 AM

🚨 $TXMD Legal Update – 9/5 Filing TXMD just filed new legal authority arguing the court — not BDO — should decide the dispute with Mayne. They cite a new ruling (Aztar v. PKN) from the same Delaware court showing that when there’s disagreement about arbitration, the judge must decide — not an outside expert. ⚖️ If the judge agrees, TXMD stays in court & keeps leverage. This would derail Mayne’s motion to delay the case. Rubric likely supports this push for full trial.

0 · Reply

jfer333 Aug. 30 at 3:13 AM

🚨 $TXMD Update – Court Filing 8/29 TXMD & Mayne just submitted a joint litigation schedule — signaling they’re preparing for full discovery & trial if the judge denies Mayne’s motion to stay. 🗓️ Key dates proposed: • Answer due: 14 days after ruling • Discovery begins: 21 days after ruling • Expert reports due: Mar–May 2026 • Case ready for trial: Late 2026 ⚖️ Significance: Court hasn’t ruled yet, but this shows TXMD is pushing forward, and both sides are gearing up for a serious legal fight. TXMD is looking to jam up the Cosette/Mayne merger for over a year. This has serious legal cost implications for Mayne and potential delays to their existing merger. Looks like TXMD is forcing these guys to open their check book. The lawsuit is for $11M. Legal costs could be as much as $3M for all parties.

2 · Reply

Market Cap	12.41M
Revenue (ttm)	1.76M
Net Income (ttm)	-2.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-123.86%
Debt to Equity Ratio	0.00

Volume	20,500
Avg Vol	18,488
Day's Range	N/A - N/A
Shares Out	11.57M
Stochastic %K	71%
Beta	0.58
Analysts	Strong Buy
Price Target	$5.00